CNS Pharmaceuticals

CNSP · NASDAQ

$4.99−$0.01 (−0.20%)TodayMarket closed ·
Prev close $5.00

Who owns CNSP

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 20.1% of CNSP’s shares.

  • Ikarian Capital LLC9.3%
  • Adar1 Capital Management LLC4.8%
  • Stonepine Capital Management, LLC2.8%
  • Boothbay Fund Management, LLC0.9%
  • Next 6 largest institutions2.2%
  • All other shareholders79.9%
Top institutional holders of CNSP
HolderShares% of shares
Ikarian Capital LLC135.83K9.30%
Adar1 Capital Management LLC70.00K4.79%
Stonepine Capital Management, LLC41.57K2.85%
Boothbay Fund Management, LLC13.52K0.93%
Vanguard Fiduciary Trust Co10.23K0.70%
Charles (Faith L.)7.10K0.49%
Vanguard Capital Management, LLC6.99K0.48%
Levin (Rami)4.75K0.33%
Fisher (Michal)2.00K0.14%
UBS Switzerland AG8000.05%

Largest mutual fund holders

Top mutual fund holders of CNSP
HolderShares% of shares
Fidelity Extended Market Index Fund8.32K0.57%
Vanguard Extended Market Index Fund6.99K0.48%
Fidelity Series Total Market Index Fund5550.04%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $44.00K (2 trades) of CNSP on the open market, with no sales.

Latest CNSP insider transactions
InsiderTypeSharesValue
Levin RamiOption exercise4.75K—
Levin RamiOption exercise4.75K—
Fisher MichalBuy2.00K$10.00K
Charles Faith L.Buy7.10K$34.00K

Short interest

Settled Sep 30, 2026

Shares short
898
Days to cover
1.00
% of shares outstanding
0.06%
Average daily volume
3.01K
Change since last report
−69.8%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.